Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Artigo em Inglês | MEDLINE | ID: mdl-15711607

RESUMO

OBJECTIVE: To evaluate the efficacy of bicalutamide vs cyproterone acetate in preventing PSA flare (as a surrogate for tumour flare) for patients requiring luteinizing hormone-releasing hormone (LHRH) analogue therapy for prostate cancer. PATIENTS AND METHODS: In this pilot study, 40 men were randomized 1 : 1 to bicalutamide 50 mg o.d. or cyproterone acetate 100 mg t.i.d. 5 days prior to goserelin acetate and continued for 21 days thereafter. PSA, luteinizing hormone (LH), follicle-stimulating hormone (FSH) and testosterone were obtained before treatment and on days 6, 8, 10, 16, 21 and 28. Primary end point was PSA. Hormone profile and clinical features including urinary symptoms and bone pain were secondary end points. RESULTS: Both groups were equally matched apart from serum creatinine and ALP. The speed and magnitude of the percentage change in median PSA from baseline was increased for the CPA group but there was no statistically significant difference in the two groups. Although those receiving bicalutamide all showed a testosterone peak, this remained within the normal range. No difference in the frequency of drug-specific adverse events was found. None of the patients died or developed cord compression during the study period. CONCLUSION: Bicalutamide is able to suppress the initial PSA surge as effectively as cyproterone acetate albeit slightly delayed. A statement whether bicalutamide is equally good at preventing clinical flare cannot be made and should be assessed in an appropriately powered study.


Assuntos
Antagonistas de Androgênios/farmacologia , Antagonistas de Androgênios/uso terapêutico , Anilidas/farmacologia , Anilidas/uso terapêutico , Antineoplásicos Hormonais/efeitos adversos , Antineoplásicos Hormonais/uso terapêutico , Biomarcadores Tumorais/sangue , Acetato de Ciproterona/farmacologia , Acetato de Ciproterona/uso terapêutico , Gosserrelina/efeitos adversos , Gosserrelina/uso terapêutico , Neoplasias da Próstata/tratamento farmacológico , Idoso , Humanos , Injeções Subcutâneas , Masculino , Nitrilas , Dor/induzido quimicamente , Compostos de Tosil
2.
Eur Urol ; 46(4): 444-9; discussion 449-50, 2004 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-15363558

RESUMO

INTRODUCTION: Radical prostatectomy is an increasingly popular treatment option for clinically localised prostate cancer, yet PSA outcome figures are rare in the UK. This makes it difficult to establish appropriate criteria for case selection. We conducted an audit of PSA recurrence of 5 large centres in the south of England and investigated the use of pre-operative PSA to improve case selection and outcome. METHOD: 854 patients notes were audited for pre-operative staging parameters and follow-up data obtained. Patients with neoadjuvant and adjuvant treatment as well as patients with incomplete data and follow-up were excluded. RESULT: Median follow-up was 52 months for the remaining 663 patients. Median PSA was 10 ng/ml. A large improvement of PSA recurrence free survival rates was observed from 1988 to 1998 as a result of change in case selection and stage migration. Overall Kaplan-Meier PSA recurrence free survival probability at 1, 3, 5 and 8 years was 0.83, 0.69, 0.60 and 0.48, respectively. Five-year PSA recurrence free survival probability for PSA ranges <4 ng/ml, 4.1-10 ng/ml, 10.1-20 ng/ml and >20 ng/ml was 0.82, 0.73, 0.59 and 0.20, respectively (Wilcoxon, p < 0.0001). A simulation of biochemical recurrence free survival for patient cohorts with stepwise reduced inclusion PSAs suggests an improved outcome for patients with a pre-operative inclusion PSA of <12 ng/ml. Further reduction of the inclusion PSA does not improve outcome. CONCLUSION: Intermediate PSA recurrence free survival has improved over time in England. PSA recurrence free survival estimates are less optimistic compared to frequently quoted American figures. A reduced pre-operative PSA cut-off for case selection may be used to improve outcome.


Assuntos
Adenocarcinoma/cirurgia , Seleção de Pacientes , Prostatectomia , Neoplasias da Próstata/cirurgia , Adenocarcinoma/mortalidade , Adenocarcinoma/patologia , Humanos , Masculino , Pessoa de Meia-Idade , Próstata/patologia , Antígeno Prostático Específico/sangue , Prostatectomia/mortalidade , Prostatectomia/estatística & dados numéricos , Neoplasias da Próstata/mortalidade , Neoplasias da Próstata/patologia , Reino Unido
3.
BJU Int ; 93(6): 725-9, 2004 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-15049980

RESUMO

OBJECTIVES: To report an audit of preoperative staging variables, case selection, stage migration and prostate-specific antigen (PSA) recurrence at five large centres in the south of England. To establish PSA outcome values after radical prostatectomy for clinically localized prostate cancer in the UK, and enable appropriate patient counselling. PATIENTS AND METHODS: The notes of 854 patients were audited for preoperative staging variables and follow-up data obtained. Patients with neoadjuvant and adjuvant treatment, and with incomplete data and follow-up, were excluded. RESULTS: The median follow-up was 52 months for the remaining 663 patients; the median PSA level was 10 ng/mL. There was a large migration towards lower PSA and stage; this translated into improved PSA survival rates. The overall Kaplan-Meier PSA recurrence-free survival probability at 1, 3, 5 and 8 years was 0.83, 0.69, 0.60 and 0.48, respectively. The 5-year PSA recurrence-free survival probabilities for PSA levels of < 4, 4.1-10, 10.1-20 and > 20 ng/mL were 0.82, 0.73, 0.59 and 0.20, respectively (Wilcoxon, P < 0.001). The PSA recurrence-free survival probabilities for biopsy Gleason grade 2-4, 5 and 6, 7 and 8-10 at 5 years were 0.70, 0.61, 0.55 and 0.21, respectively (Wilcoxon, P < 0.001). Similarly, the 5-year PSA recurrence-free survival probabilities for clinical stages T1a and 1b, T1c, T2a and T2b were 0.79, 0.62, 0.57 and 0.44, respectively (Wilcoxon, P = 0.0012). CONCLUSION: With better case selection the intermediate oncological outcome has improved over time in the UK. PSA recurrence-free survival estimates are less optimistic than the frequently quoted American values. The present values may be used to help in counselling British patients before radical prostatectomy.


Assuntos
Adenocarcinoma/cirurgia , Recidiva Local de Neoplasia/diagnóstico , Antígeno Prostático Específico/sangue , Prostatectomia/mortalidade , Neoplasias da Próstata/cirurgia , Adenocarcinoma/mortalidade , Adenocarcinoma/patologia , Biópsia/métodos , Humanos , Masculino , Auditoria Médica , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/sangue , Estadiamento de Neoplasias/métodos , Cuidados Pré-Operatórios/métodos , Estudos Prospectivos , Próstata/patologia , Neoplasias da Próstata/mortalidade , Neoplasias da Próstata/patologia , Análise de Sobrevida
4.
Eur Urol ; 45(1): 18-25, 2004 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-14667510

RESUMO

OBJECTIVES: To review the evidence underlying the diagnosis, pathology and treatment of lymphoedema of the lower extremities and genitalia from or following the treatment for urological cancer, and to suggest possible underlying pathophysiological mechanisms that may explain its development. METHODS: Reviews of the epidemiological, surgical, and scientific literature and personal experience of treatment of patients are used to build a picture of clinical setting and the physiological principles underlying lymphoedema of the leg. RESULTS: Lymphoedema of the leg and genitals results in serious morbidity for the patient. The incidence is largely unknown, but varies according to the type and location of tumours and may be up to 50% in advanced stages of penile carcinoma, or following its treatment. Although the aetiology of the condition is either iatrogenic, or associated with malignancy, the underlying pathophysiology is not well understood. CONCLUSIONS: Recent studies in breast cancer related lymphoedema point to underlying vascular as well as lymphatic problems, but the parallels with lower limb lymphoedema are not known.


Assuntos
Doenças dos Genitais Masculinos/etiologia , Linfedema/etiologia , Neoplasias Urológicas/complicações , Doenças dos Genitais Masculinos/diagnóstico , Doenças dos Genitais Masculinos/epidemiologia , Doenças dos Genitais Masculinos/terapia , Humanos , Perna (Membro) , Linfedema/diagnóstico , Linfedema/epidemiologia , Linfedema/terapia , Masculino , Prevalência , Sistema Urogenital/fisiologia
5.
BJU Int ; 92(6): 610-3, 2003 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-14511045

RESUMO

OBJECTIVES: To present the results of a minimally invasive treatment of symptomatic simple renal cysts, and to propose an algorithm for their management. PATIENTS AND METHODS: Seventeen patients presenting with suspected symptomatic simple renal cysts were referred for trial aspiration; 16 presented with loin pain and one with a flank mass. If the cyst and symptoms recurred after a temporary response, they were managed by re-aspiration with sclerotherapy using 95% ethanol, or by laparoscopic de-roofing of the cyst. RESULTS: Of the 17 patients referred, one failed to respond to aspiration and was excluded from further analysis. Three patients had sustained pain relief from simple aspiration alone, 13 required further treatment for symptom relapse, of whom six had aspiration and sclerotherapy, and seven had laparoscopic de-roofing. After a mean follow-up of 17 months, pain had recurred in all five patients originally presenting with pain and managed by sclerotherapy, and the patient who presented with a painless mass from a large cyst also developed pain after sclerotherapy. In contrast, the subsequent seven patients managed by laparoscopic treatment are pain-free at a mean follow-up of 17.7 months. CONCLUSION: Evaluation including a diagnostic aspiration is essential to diagnose a symptomatic cyst. When treatment is indicated, laparoscopic de-roofing appears to be more effective than sclerotherapy.


Assuntos
Etanol/uso terapêutico , Doenças Renais Císticas/terapia , Soluções Esclerosantes/uso terapêutico , Escleroterapia/métodos , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Seguimentos , Humanos , Doenças Renais Císticas/cirurgia , Laparoscopia/métodos , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Dor/etiologia , Sucção , Resultado do Tratamento
6.
Afr. j. urol. (Online) ; 9(2): 59-64, 2003.
Artigo em Inglês | AIM (África) | ID: biblio-1258175

RESUMO

Objectives To determine the prevalence of hypospadias; patent processus vaginalis; umbilical hernia; splenomegaly and cryptorchidism in primary school boys of a Nigerian community. Patients and Methods A community-based observational study using the cluster-sampling method was done. One thousand and ninety-six primary school boys aged between 5 and 13 years from five randomly selected schools in the administrative district of the Ogbaru Local Government Area (LGA) of Eastern Nigeria participated in this study; while in only 1080 boys some specific information on umbilical hernia was available. Each participant underwent a general; abdominal; groin and peno-scrotal physical examination. Results The prevalence of hypospadias was 1.1and this was equivalent to the incidence. The prevalence of a patent processus vaginalis was 1.0with an estimated incidence of 1.3. Cryptorchidism was present in 0.8and retractile testis in 3.2. The prevalence of umbilical hernia was 26and the splenomegaly rate was 7. Conclusion The incidence and prevalence of simple hypospadias was higher than previously suggested by a tertiary hospital-based report from Western Nigeria. Umbilical hernia was very common but apparently only few patients needed treatment. The incidence of a patent processus vaginalis was similar to that reported in other parts of the world; although surgical correction was delayed. Splenomegaly was common; not only due to endemic malaria; but also due to sickle-cell disease; with implications for the management of childhood trauma in this part of the world


Assuntos
Criptorquidismo , Hérnia , Hipospadia , Prevalência , Instituições Acadêmicas , Esplenomegalia
7.
BJU Int ; 90(4): 364-7, 2002 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12175390

RESUMO

OBJECTIVE: To evaluate the early results of hand-assisted radical nephrectomy and nephroureterectomy in our institution. PATIENTS AND METHODS: The records of 13 patients with malignant disease of the kidney who underwent hand-assisted laparoscopic radical nephrectomy and nephroureterectomy were reviewed retrospectively. Clinical outcomes were compared with a series of 16 patients who underwent similar procedures via a standard laparoscopic approach. RESULTS: There were three major hand-port wound complications in those who underwent hand-assisted procedures, while one other patient required conversion because of technical failure of the device. The operative duration, length of hospital stay, estimated blood loss, transfusion rate, analgesic requirement, conversion rates, and minor complications were similar between the hand-assisted and standard laparoscopy groups. CONCLUSION: There was little difference between hand-assisted and standard laparoscopy in operative duration or recovery, but there were problems with wound complications which may be related to the hand-assisted approach. We have consequently abandoned the technique in favour of a standard laparoscopic approach.


Assuntos
Carcinoma de Células de Transição/cirurgia , Neoplasias Renais/cirurgia , Nefrectomia/efeitos adversos , Idoso , Idoso de 80 Anos ou mais , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Nefrectomia/instrumentação , Nefrectomia/métodos , Ureter/cirurgia
9.
BJU Int ; 88(9): 941-5, 2001 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-11851618

RESUMO

OBJECTIVE: To determine the prevalence and characteristics of cryptorchidism among primary schoolboys in a Nigerian district. SUBJECTS AND METHODS: The district selected had 35 primary schools with 23,342 pupils, consisting of 11,275 girls and 11,967 boys. Using a cluster-sampling technique, five primary schools were visited; 1096 boys (aged 5-13 years) participated in the study, giving a sampling ratio of 1:11. The boys underwent a clinical examination of the groin, scrotum and abdomen. RESULTS: Cryptorchidism was found in nine subjects, giving a prevalence rate of 0.82%. All the undescended testes were unilateral, of which five were right-sided. Eight of the testes were intracanalicular and one was at the external ring. There were no cases of orchidopexy. CONCLUSION: The prevalence of cryptorchidism among primary schoolboys in this district of Nigeria was high, at eight per 1000. Delayed diagnosis and treatment remains a problem because of the prevailing socio-economic factors. However, the incidence of cryptorchidism was similar to that reported in other parts of the world.


Assuntos
Criptorquidismo/epidemiologia , Adolescente , Estatura , Peso Corporal , Criança , Pré-Escolar , Análise por Conglomerados , Humanos , Incidência , Masculino , Nigéria/epidemiologia , Prevalência , Fatores Socioeconômicos
10.
BJU Int ; 86(1): 43-6, 2000 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-10886081

RESUMO

OBJECTIVE: To evaluate the usefulness of a tracer of 1% ethanol in 1. 5% glycine in the early detection of irrigation fluid absorption during transurethral resection of the prostate (TURP). PATIENTS AND METHODS: Patients (120) undergoing TURP were irrigated with 1% ethanol in 1.5% glycine solution and their expired air tested for alcohol every 10 min during the procedure. RESULTS: In all, 112 patients were assessed; over half of the patients absorbed the irrigation fluid and they had a significantly lower postoperative serum sodium concentration (P < 0.002). Fourteen patients (12.5%) absorbed over 500 mL and two (1.8%) developed clinical features of the TUR syndrome. The experience of the surgeon, the weight of resected chips and the operative duration were not significantly predictive of absorption. CONCLUSION: A tracer amount of ethanol in the irrigant is reliable for detecting absorption. Irrigating fluid absorption was unpredictable, thus supporting the case for routine monitoring.


Assuntos
Etanol , Glicina , Doenças Prostáticas/cirurgia , Irrigação Terapêutica/métodos , Ressecção Transuretral da Próstata/métodos , Absorção , Idoso , Idoso de 80 Anos ou mais , Combinação de Medicamentos , Humanos , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...